BUY Conviction3/5 Analysis quality68/100 now
The analyst recommends Laboratory Corporation of America, citing its significant share of independent lab testing in the US. Despite expected declines in sales and earnings due to reduced COVID testing, he believes the 'triple-demic' will drive increased demand for virus testing, leading to a potential upside surprise in its Q4 earnings.
“if there is an increase in demand for these virus testings you are going to see it here Shares are down more than more than the others here down about 20 percent this year as sales are expected lower by about 7.3 percent and again just like we saw with um with Quest Diagnostics earnings are expected down 30 percent.”